All these results demonstrated that MAPK/JNK signalling was functionally taking part in Sec62‐mediated CRC metastasis, and targeting MAPK/JNK pathway by JNK inhibitors might be helpful for Sec62 overexpressing CRC metastasis. Here, SEC62 is linked to colorectal carcinoma.